[LXRX] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
03-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -29.69%
YoY- -19.91%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 162 317 24 28 39 35 37 167.39%
PBT -50,525 -44,904 -31,934 -30,494 -23,387 -24,587 -23,476 66.61%
Tax 2,854 1,152 -1,029 216 292 580 96 857.69%
NP -50,525 -44,904 -30,905 -30,710 -23,679 -25,167 -23,572 66.16%
Tax Rate - - - - - - - -
Total Cost 50,687 45,221 30,929 30,738 23,718 25,202 23,609 66.34%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -31,188.27 -14,165.30 -128,770.83 -109,678.57 -60,715.38 -71,905.71 -63,708.11 -37.85%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.21 -0.22 -0.16 -0.16 -0.14 -0.17 -0.16 19.85%
EPS Diluted -0.21 -0.22 -0.16 -0.16 -0.14 -0.17 -0.16 19.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.